Update in Pulmonary Vascular Disease 2016 and 2017.
作者信息
Brittain Evan L, Thennapan Thennapan, Maron Bradley A, Chan Stephen Y, Austin Eric D, Spiekerkoetter Edda, Bogaard Harm J, Guignabert Christophe, Paulin Roxane, Machado Roberto F, Yu Paul B
机构信息
1 Division of Cardiovascular Medicine, Department of Medicine.
2 Vanderbilt Translational and Clinical Cardiovascular Research Center.
出版信息
Am J Respir Crit Care Med. 2018 Jul 1;198(1):13-23. doi: 10.1164/rccm.201801-0062UP.
Abstract
摘要
相似文献
1
Update in Pulmonary Vascular Disease 2016 and 2017.2016年和2017年肺血管疾病的进展
Am J Respir Crit Care Med. 2018 Jul 1;198(1):13-23. doi: 10.1164/rccm.201801-0062UP.
2
Update in pulmonary vascular diseases 2013.2013年肺血管疾病的最新进展
Am J Respir Crit Care Med. 2014 Oct 1;190(7):738-43. doi: 10.1164/rccm.201405-0871UP.
3
Pulmonary vascular disease: our need to understand.
Chest. 1998 Jul;114(1):8-9. doi: 10.1378/chest.114.1.8.
4
Phosphodiesterase 5 inhibitors in vascular systemic disorders.
Joint Bone Spine. 2012 Jul;79(4):338-40. doi: 10.1016/j.jbspin.2011.12.009. Epub 2012 Mar 10.
5
PVDOMICS: A Multi-Center Study to Improve Understanding of Pulmonary Vascular Disease Through Phenomics.PVDOMICS：一项通过表型组学改善肺血管疾病理解的多中心研究。
Circ Res. 2017 Oct 27;121(10):1136-1139. doi: 10.1161/CIRCRESAHA.117.311737.
6
Genetic abnormalities of the endothelium.内皮细胞的基因异常。
Microsc Res Tech. 2003 Jan 1;60(1):30-7. doi: 10.1002/jemt.10240.
7
Microvascular Disease in Chronic Thromboembolic Pulmonary Hypertension: Hemodynamic Phenotyping and Histomorphometric Assessment.慢性血栓栓塞性肺动脉高压中的微血管病变：血流动力学表型和组织形态计量评估。
Circulation. 2020 Feb 4;141(5):376-386. doi: 10.1161/CIRCULATIONAHA.119.041515. Epub 2020 Jan 3.
8
Update in Pulmonary Vascular Disease 2015.2015年肺血管疾病进展
Am J Respir Crit Care Med. 2016 Jun 15;193(12):1337-44. doi: 10.1164/rccm.201601-0143UP.
9
Early detection of pulmonary vascular disease in pulmonary arterial hypertension: time to move forward.肺动脉高压肺血管病的早期检测：是时候向前推进了。
Eur Heart J. 2011 Oct;32(20):2489-98. doi: 10.1093/eurheartj/ehr160. Epub 2011 May 26.
10
Quantitative videocapillaroscopy correlates with functional respiratory parameters: a clue for vasculopathy as a pathogenic mechanism for lung injury in systemic sclerosis.定量毛细血管镜检查与功能性呼吸参数相关：血管病变作为系统性硬化症肺损伤发病机制的线索。
Arthritis Res Ther. 2018 Dec 19;20(1):281. doi: 10.1186/s13075-018-1775-9.
引用本文的文献
1
Mechanism of Phellodendron and Anemarrhena Drug Pair on the Treatment of Liver Cancer Based on Network Pharmacology and Bioinformatics.基于网络药理学和生物信息学的黄柏与知母药对治疗肝癌的作用机制
Front Oncol. 2022 Apr 7;12:838152. doi: 10.3389/fonc.2022.838152. eCollection 2022.
2
Clinical application of pulmonary vascular resistance in patients with pulmonary arterial hypertension.肺血管阻力在肺动脉高压患者中的临床应用
J Cardiothorac Surg. 2021 Oct 20;16(1):311. doi: 10.1186/s13019-021-01696-4.
3
FHIT, a Novel Modifier Gene in Pulmonary Arterial Hypertension.脆性组氨酸三联体（FHIT），肺动脉高压的一个新型修饰基因。
Am J Respir Crit Care Med. 2019 Jan 1;199(1):83-98. doi: 10.1164/rccm.201712-2553OC.
本文引用的文献
1
Right Ventricular Myofilament Functional Differences in Humans With Systemic Sclerosis-Associated Versus Idiopathic Pulmonary Arterial Hypertension.特发性肺动脉高压与系统性硬化症相关肺动脉高压患者右心室肌原纤维功能差异。
Circulation. 2018 May 29;137(22):2360-2370. doi: 10.1161/CIRCULATIONAHA.117.033147. Epub 2018 Jan 19.
2
Sildenafil for improving outcomes in patients with corrected valvular heart disease and persistent pulmonary hypertension: a multicenter, double-blind, randomized clinical trial.西地那非改善瓣膜病合并持续性肺动脉高压患者结局的多中心、双盲、随机临床试验。
Eur Heart J. 2018 Apr 14;39(15):1255-1264. doi: 10.1093/eurheartj/ehx700.
3
Increased Echocardiographic Pulmonary Pressure in HIV-infected and -uninfected Individuals in the Veterans Aging Cohort Study.在退伍军人老龄化队列研究中，感染和未感染 HIV 的个体的超声心动图肺动脉压升高。
Am J Respir Crit Care Med. 2018 Apr 1;197(7):923-932. doi: 10.1164/rccm.201708-1555OC.
4
17β-Estradiol Directly Lowers Mitochondrial Membrane Microviscosity and Improves Bioenergetic Function in Skeletal Muscle.17β-雌二醇直接降低骨骼肌线粒体膜微粘度并改善其生物能量功能。
Cell Metab. 2018 Jan 9;27(1):167-179.e7. doi: 10.1016/j.cmet.2017.10.003. Epub 2017 Nov 2.
5
Mild Elevation of Pulmonary Arterial Pressure as a Predictor of Mortality.肺动脉压轻度升高可预测死亡率。
Am J Respir Crit Care Med. 2018 Feb 15;197(4):509-516. doi: 10.1164/rccm.201706-1215OC.
6
Loss of SMAD3 Promotes Vascular Remodeling in Pulmonary Arterial Hypertension via MRTF Disinhibition.SMAD3 缺失通过抑制肌球蛋白重链相关蛋白激酶（MRTF）促进肺动脉高压血管重构。
Am J Respir Crit Care Med. 2018 Jan 15;197(2):244-260. doi: 10.1164/rccm.201702-0386OC.
7
PVDOMICS: A Multi-Center Study to Improve Understanding of Pulmonary Vascular Disease Through Phenomics.PVDOMICS：一项通过表型组学改善肺血管疾病理解的多中心研究。
Circ Res. 2017 Oct 27;121(10):1136-1139. doi: 10.1161/CIRCRESAHA.117.311737.
8
Prognostic Effect and Longitudinal Hemodynamic Assessment of Borderline Pulmonary Hypertension.边缘性肺动脉高压的预后影响和纵向血流动力学评估。
JAMA Cardiol. 2017 Dec 1;2(12):1361-1368. doi: 10.1001/jamacardio.2017.3882.
9
Inhibition of pyruvate dehydrogenase kinase improves pulmonary arterial hypertension in genetically susceptible patients.抑制丙酮酸脱氢酶激酶可改善遗传易感患者的肺动脉高压。
Sci Transl Med. 2017 Oct 25;9(413). doi: 10.1126/scitranslmed.aao4583.
10
Pulmonary Arterial Hypertension With Abnormal V/Q Single-Photon Emission Computed Tomography.肺动脉高压伴异常通气/血流比单光子发射计算机断层扫描。
JACC Cardiovasc Imaging. 2018 Oct;11(10):1487-1493. doi: 10.1016/j.jcmg.2017.07.026. Epub 2017 Oct 18.
Zotero 插件